Cargando…

Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment

Detalles Bibliográficos
Autor principal:	The Editors of The Lancet Diabetes & Endocrinology
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Lancet, Diabetes & Endocrinology 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900581/ https://www.ncbi.nlm.nih.gov/pubmed/30056841 http://dx.doi.org/10.1016/S2213-8587(18)30146-3

Ejemplares similares

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
por: Pearson-Stuttard, Jonathan, et al.
Publicado: (2018)

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
por: Pearson-Stuttard, Jonathan, et al.
Publicado: (2018)

COVID-19 and diabetes: a co-conspiracy?
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Food for thought during school closures
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Technology in the COVID-19 era: pushing the boundaries
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

COVID-19 and Racism—a double edged dagger
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Obesity and COVID-19: Blame isn't a strategy
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Indigenous peoples: resilience in the face of adversity
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Obesity-related stigma—hiding in plain sight
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

COVID-19: underlying metabolic health in the spotlight
por: The Lancet Diabetes & Endocrinology
Publicado: (2020)

Coronavirus vaccine? Join the queue
por: The Lancet Diabetes & Endocrinology
Publicado: (2021)

Long COVID: the elephant in the room
por: The Lancet Diabetes & Endocrinology
Publicado: (2022)

The power of resilience
por: The Lancet Diabetes & Endocrinology
Publicado: (2022)

Prioritising COVID-19 over everything: the unintended harm
por: The Lancet Diabetes & Endocrinology
Publicado: (2022)

Food policies: in times of COVID-19 and beyond
por: The Lancet Diabetes & Endocrinology
Publicado: (2021)

Childhood obesity: a growing pandemic
por: The Lancet Diabetes & Endocrinology
Publicado: (2022)

Vitamin D and COVID-19: why the controversy?
por: The Lancet Diabetes & Endocrinology
Publicado: (2021)

The Andean Latin-American burden of diabetes attributable to high body mass index: A comparative risk assessment
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2020)

Learning from a retraction
por: The Editors of the Lancet Group
Publicado: (2020)

Retraction—Chinese medical personnel after the COVID-19 pandemic
por: The Editors of The Lancet
Publicado: (2023)

Global burden of type 2 diabetes attributable to non-high body mass index from 1990 to 2019
por: Wu, Jingjing, et al.
Publicado: (2023)

Trends in deaths and disability-adjusted life-years of stroke attributable to high body-mass index worldwide, 1990–2019
por: Guo, Xiucai, et al.
Publicado: (2023)

Retraction—Chinese medical staff request international medical assistance in fighting against COVID-19
por: The Editors of The Lancet Global Health
Publicado: (2020)

Trends of the burden of type 2 diabetes mellitus attributable to high body mass index from 1990 to 2019 in China
por: Wang, Jianglin, et al.
Publicado: (2023)

Retracted: Sexual Dysfunction in Women with Diabetic Kidney
por: International Journal of Endocrinology,
Publicado: (2019)

Worldwide burden of diabetes
por: Bhutani, Jaikrit, et al.
Publicado: (2014)

Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Worldwide burden of cancer attributable to HPV by site, country and HPV type
por: de Martel, Catherine, et al.
Publicado: (2017)

The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990–2019: An analysis of the Global Burden of Disease Study
por: Zhang, Xuexue, et al.
Publicado: (2022)

Spatial and Temporal Trends in Pancreatic Cancer Burden Attributable to High Body Mass Index at the Global and National Levels
por: Cao, Fei, et al.
Publicado: (2023)

The global burden and temporal trend of cancer attributable to high body mass index: Estimates from the Global Burden of Disease Study 2019
por: Zhi, Xing, et al.
Publicado: (2022)

Retraction and republication - effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study
por: The Editors of eBioMedicine
Publicado: (2022)

Worldwide burden attributable to diet high in red meat from 1990 to 2019
por: Liu, Dan, et al.
Publicado: (2022)

The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study
por: Dai, Haijiang, et al.
Publicado: (2020)

A comparison of the burden of knee osteoarthritis attributable to high body mass index in China and globally from 1990 to 2019
por: Song, Min, et al.
Publicado: (2023)

Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019
por: Li, Songbo, et al.
Publicado: (2022)

PREGNANCY OUTCOME IN GESTATIONAL DIABETES COMPARED TO BODY MASS INDEX
por: Sabolović Rudman, Senka, et al.
Publicado: (2019)

Proportion of Mortality Attributable to Tobacco Worldwide
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Non-communicable diseases deaths attributable to high body mass index in Chile
por: Riquelme, Ricardo, et al.
Publicado: (2021)

Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: The Lancet Editors
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ic1ikun9omum2msgi6tn8t45qv